Evidence map›Paper›PMID 36856974›Full record

ArticleJournal of nephrology2023

Lessons for the clinical nephrologist: a rare case with MGRS characterized by combined crystalline light chain proximal tubulopathy and crystal-storing histiocytosis responding to daratumumab.

Ai-Bo Qin, Xiao-Juan Yu, Xi-Zi Zheng, Su-Xia Wang, Fu-de Zhou, Ming-Hui Zhao

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ai-Bo QinRenal Division, Department of Medicine, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, China.ORCID 0000-0002-3502-9829
Xiao-Juan YuRenal Division, Department of Medicine, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, China.
Xi-Zi ZhengRenal Division, Department of Medicine, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, China.
Su-Xia WangRenal Division, Department of Medicine, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, China.
Fu-de ZhouRenal Division, Department of Medicine, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, China. zhoufude1801@vip.sina.com.
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, China.

Funding

CAMS Innovation Fund for Medical Sciences 2019-I2M-5-046the National Natural Science Foundation of China 82070747
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HistiocytosisKidney DiseasesParaproteinemiasAntibodies, MonoclonalHumansNephrologistsAntibodies, MonoclonaldaratumumabCrystal-storing histiocytosisDaratumumabLight chain proximal tubulopathyMonoclonal gammopathyMonoclonal gammopathy of renal significance

Identifiers

PMID36856974
PMCPMC10227152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.